Aarti Drugs rose 5.23% to Rs 433.90 at 11:28 IST on BSE, with the stock extending Friday's rally triggered by the company reporting strong Q4 earnings.
Meanwhile, the S&P BSE Sensex was up 65.94 points or 0.29% at 22,469.83.
On BSE, so far 75,000 shares were traded in the counter as against average daily volume of 8,506 shares in the past one quarter.
The stock hit a high of Rs 451 so far during the day, which is a record high for the counter. The stock hit a low of Rs 416 so far during the day. The stock had hit a 52-week low of Rs 165 on 24 September 2013.
The stock had outperformed the market over the past one month till 2 May 2014, surging 57.12% compared with the Sensex's 0.65% fall. The scrip had also outperformed the market in past one quarter, jumping 84.04% as against Sensex's 9.21% rise.
The small-cap company has equity capital of Rs 12.11 crore. Face value per share is Rs 10.
Shares of Aarti Drugs have risen 21.93% in two trading sessions from a recent low of Rs 355.85 on 30 April 2014, after the company after market hours on 30 April 2014 reported strong Q4 March 2014 earnings. The stock had rallied 15.88% to settle at Rs 412.35 on Friday, 2 May 2014. The stock market was closed on Thursday, 1 May 2014, on account of May Day.
Aarti Drugs' net profit jumped 58.94% to Rs 21.95 crore on 28.45% growth in total income from operations to Rs 283.04 crore in Q4 March 2014 over Q4 March 2013.
Aarti Drugs' board of directors at its meeting held on Wednesday, 30 April 2014, recommended final dividend of Rs 5.50 per share for the year ended 31 March 2014 (FY 2014).
Aarti Drugs after market hours on Friday, 2 May 2014 said it has commenced the new R&D center at MIDC Tarapur.
Aarti Drugs is a pharmaceutical company. The company makes generic bulk actives, advanced intermediates and specialty chemicals.
Powered by Capital Market - Live News
